CoStim Pharmaceuticals Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 18
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $248M
Latest Deal Amount

CoStim Pharmaceuticals General Information

Description

Developer of cancer immunotherapy. The company develops antibody drugs targeting immunological checkpoint control.

Contact Information

Website
www.costim.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Primary Office
  • 200 Clarendon Street
  • 54th Floor
  • Boston, MA 02116
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CoStim Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 17-Feb-2014 $248M 000.00 00000 Completed Pre-Clinical Trials
3. Early Stage VC 23-Dec-2013 000.00 Completed Product Development
2. Early Stage VC (Series A) 29-Mar-2013 $10M $10.7M 000.00 Completed Product Development
1. Early Stage VC 01-May-2012 $700K $700K Completed Generating Revenue/Not Profitable
To view CoStim Pharmaceuticals’s complete valuation and funding history, request access »

CoStim Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 00,000,000 00.000000 00 00 00 00 00.000
Series A2 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view CoStim Pharmaceuticals’s complete cap table history, request access »

CoStim Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer immunotherapy. The company develops antibody drugs targeting immunological checkpoint control.
Biotechnology
Boston, MA
18 As of 2013
000.00
0000 0000-00-00
000000&0 000.00

0000000

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000

00000 00

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cill
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CoStim Pharmaceuticals Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Compass Therapeutics Venture Capital-Backed Cambridge, MA 00 00000 00000000
00000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000000000 Venture Capital-Backed Seattle, WA 00 00000 00000000000 00000
00000 Private Equity-Backed San Diego, CA 00 00000 00000000 00000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
You’re viewing 5 of 15 competitors. Get the full list »

CoStim Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoStim Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atlas Venture Venture Capital Minority 000 0000 000000 0
Curative Ventures Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
Mass General Brigham Ventures Venture Capital Minority 000 0000 000000 0
To view CoStim Pharmaceuticals’s complete investors history, request access »